For: | Sun SS, Li WD, Chen JL. Transarterial chemoembolization combined with radiofrequency ablation in the treatment of large hepatocellular carcinoma with stage C. World J Clin Cases 2022; 10(33): 12156-12163 [PMID: 36483812 DOI: 10.12998/wjcc.v10.i33.12156] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i33/12156.htm |
Number | Citing Articles |
1 |
Jingyi Dai, Yadi Ding, Qiaomei Zheng, Guixin Zhao, Lingqing Zou, Jun Zhao, Yu Luo, Virasakdi Chongsuvivatwong. Survival Benefits of Transarterial Chemoembolization Plus Ablation Therapy in Patients With Intermediate or Advanced Hepatocellular Carcinoma: A Propensity Score Matching Study. Cancer Management and Research 2025; : 483 doi: 10.2147/CMAR.S511364
|
2 |
Ragaey Ahmad Eid, Ali M. Abdel Fattah, Alaa Farouk Haseeb, Ahmed Moheyeldien Hamed, Marwa Abdallah Shaker. Percutaneous radiofrequency ablation for stage B1 of modified Bolondi’s subclassification for intermediate-stage hepatocellular carcinoma. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00388-7
|